Stockholm, May 08, 2023: Medical technology company Capitainer continues to focus on increased sales of its self-sampling products. By recruiting Yvonne Zar Berglund for the Sales & Distribution Manager role, Capitainer is strategically executing on its growth plans to strengthen its position in the market further.
Capitainer is currently in a strong expansion phase, focusing on offering its innovative self-sampling solutions at scale. The company has already experienced increased demand for its products in several markets and has recently partnered with several distributors.
To maximise sales growth and meet the increased demand for the products, Capitainer is recruiting Yvonne Zar Berglund, an experienced Sales & Distribution Manager. With over 30 years of experience in life science and diagnostics and a solid background in sales and business strategy, Yvonne Zar Berglund is well-equipped to take Capitainer’s sales to the next level.
“Contributing to increasing sales in a company is exciting – I’ve done it before and found it very enjoyable and rewarding. With our high-quality products, our own sales team, and skilled distributors, I’m confident we will see excellent sales figures this year,” says Yvonne Zar Berglund.
As the founder and CEO of Nordic BioSite, a leading distributor of research and diagnostic products, Yvonne was involved in starting up legal entities in seven countries and establishing partnerships with global distributors. Nordic BioSite was acquired by Adelis in 2021. Yvonne has also worked as Managing Director at AMSBIO and with sales and marketing at Amersham.
“We are delighted to welcome Yvonne Zar Berglund as our new Sales & Distribution Manager. With her extensive knowledge in life science and expertise in sales and distribution, Yvonne will be a valuable asset as we continue to grow and implement our commercialisation strategy going forward,” says Christopher Aulin, CEO of Capitainer.
For more information, please contact:
Christopher Aulin, CEO
Phone: +46 (0)708 977577
Capitainer AB is a Swedish medtech company founded in 2016. Capitainer develops and sells intelligent solutions for self-sampling of blood, plasma, and urine. The company has developed unique technologies for collecting an exact amount of fluid and then allowing it to dry. The sample card can be sent with regular mail to laboratories without needing refrigerated transports or special packaging. The precision and accuracy in Capitainer’s samples are market-leading and perform on the same level as established pipetting methods. The products can be applied within several market segments, for instance, clinical biomarkers, therapeutic drug monitoring, genomics, drug development, drug abuse and doping testing, and R&D and clinical studies.